The company uses a scale of -100 to +100 to rank companies – as you'd expect, higher is better – and all of the top 20 pharma companies included in this year's survey were in positive territory.

After several months, inflammatory disease medication Dupixent has finally reclaimed its spot atop the rankings for over-the-counter (OTC ... of 1.1 billion while spending a mere $4 million. For ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...